Human Orf with Immune-mediated reactions: a systematic review

L Rossi, G Tiecco, M Venturini, F Castelli… - Microorganisms, 2023 - mdpi.com
Background: Orf is a highly contagious zoonosis caused by Orf virus (ORFV), which is
endemic in sheep and goats worldwide. Human Orf is usually a self-limiting disease, but …

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer

X Huang, XY Li, WL Shan, Y Chen, Q Zhu… - Frontiers in …, 2023 - frontiersin.org
Currently, for ovarian cancer, which has the highest mortality rate among all gynecological
cancers, the standard treatment protocol is initial tumor cytoreductive surgery followed by …

[HTML][HTML] PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression

M Prat, K Coulson, C Blot, G Jacquemin… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Ovarian adenocarcinoma (OVAD) frequently metastasizes to the peritoneal
cavity and manifests by the formation of ascites, which constitutes a tumor-promoting …

Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy

M Ghasemi, L Abbasi, L Ghanbari Naeini… - Frontiers in …, 2023 - frontiersin.org
Every type of cancer tissue is theoretically more vulnerable to viral infection. This natural
proclivity has been harnessed as a new anti-cancer therapy by employing oncolytic viruses …

Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment

AL Portillo, JK Monteiro, EA Rojas, TM Ritchie… - Frontiers in …, 2023 - frontiersin.org
The ability to expand and activate natural Killer (NK) cells ex vivo has dramatically changed
the landscape in the development of novel adoptive cell therapies for treating cancer over …

[HTML][HTML] Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model

DRE Ranoa, P Sharma, CP Schane… - … for ImmunoTherapy of …, 2023 - ncbi.nlm.nih.gov
Background Treatment of some blood cancers with T cells that express a chimeric antigen
receptor (CAR) against CD19 have shown remarkable results. In contrast, CAR-T cell …

The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?

ML Franks, JH An, JW Leavenworth - Vaccines, 2024 - mdpi.com
Oncolytic virotherapy (OVT) has emerged as a promising cancer immunotherapy, and is
capable of potentiating other immunotherapies due to its capacity to increase tumor …

Identification and validation of the diagnostic characteristic genes of ovarian cancer by bioinformatics and machine learning

J Liu, L Liu, PA Antwi, Y Luo, F Liang - Frontiers in Genetics, 2022 - frontiersin.org
Background: Ovarian cancer (OC) has a high mortality rate and poses a severe threat to
women's health. However, abnormal gene expression underlying the tumorigenesis of OC …

The role of neutrophils in oncolytic orf virus-mediated cancer immunotherapy

JA Minott, JP van Vloten, L Chan, Y Mehrani, BW Bridle… - Cells, 2022 - mdpi.com
Neutrophils are innate leukocytes with diverse effector functions that allow them to respond
to pathogens rapidly. Accumulating evidence has highlighted these cells' complex roles in …

Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer

JA Minott, JP van Vloten, JGE Yates, LA Santry… - Molecular Therapy …, 2023 - cell.com
Immunotherapies revive host immune responses against tumors by stimulating innate and
adaptive immune effector cells with anti-tumor functions. Thus, detailed studies of …